BridgeBio Pharma, Inc. Annual Operating Margin in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
BridgeBio Pharma, Inc. quarterly/annual Operating Margin history and growth rate from 2019 to 2023.
  • BridgeBio Pharma, Inc. Operating Margin for the quarter ending September 30, 2024 was -250 %, a 95.8% increase year-over-year.
  • BridgeBio Pharma, Inc. annual Operating Margin for 2023 was -6.53K %, a 890% decline from 2022.
  • BridgeBio Pharma, Inc. annual Operating Margin for 2022 was -660 %, a 20.2% increase from 2021.
  • BridgeBio Pharma, Inc. annual Operating Margin for 2021 was -827 %, a 85.6% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -6.53K -5.87K -890% Jan 1, 2023 Dec 31, 2023
2022 -660 +167 +20.2% Jan 1, 2022 Dec 31, 2022
2021 -827 +4.92K +85.6% Jan 1, 2021 Dec 31, 2021
2020 -5.75K -5.1K -776% Jan 1, 2020 Dec 31, 2020
2019 -656 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.